top of page
Kicking Cancer's KRAS Expert Series with I-Fen Chang
Kicking Cancer's KRAS Expert Series with I-Fen Chang

Tue, Mar 15

|

Virtual/Live

Kicking Cancer's KRAS Expert Series with I-Fen Chang

We are pleased to host Amgen’s Vice President of Medical, I-Fen Chang, to discuss a targeted KRAS G12C treatment.

Registration is Closed
See other events

Time & Location

Mar 15, 2022, 11:00 AM – 12:30 PM EDT

Virtual/Live

About the Event

We are excited to welcome I-Fen Chang to the Kicking Cancer’s KRAS Expert Series!  I-Fen will be presenting an "Overview of a Targeted KRAS G12C Treatment by Amgen."

If you have questions for the presenter, please submit to connect@kraskickers.org by March 8th.

About I-Fen Chang

I-Fen Chang is the Vice President, Global Medical Therapeutic Area Head, Oncology at Amgen. I-Fen is a Pharm D and has over 15 years of experience in the biopharmaceutical industry with roles in medical affairs and clinical development. Prior to joining Amgen, she held the position of Worldwide Medical Lung lead at Bristol-Myers Squibb, Co. I-Fen received her Bachelor of Science in Pharmacy and Doctor of Pharmacy from Rutgers, The State University of New Jersey, College of Pharmacy in Piscataway, New Jersey. She completed her Pediatric Pharmacotherapy Residency at Texas Children’s Hospital in Houston, Texas.

This event has a group. You’re welcome to join the group once you register for the event.

Share This Event

Genentech_Logo.png_dark blue text that reads, "Genetech." Gray italicized text that reads, "a member of the Roche Group."
Blue capitalized text on a gray background. Text reads, "Amgen."
Dark blue text on top of sea foam text. Text reads, "Verastem Oncology."
Black capitalized text that reads, "Revolution Medicine."
bottom of page